Back to top
more

Zimmer Biomet (ZBH)

(Real Time Quote from BATS)

$111.17 USD

111.17
523,596

-0.12 (-0.11%)

Updated Jul 29, 2024 03:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. With operations in over 25 countries, Zimmer markets products in more than 100 countries. In 2015, Zimmer Holdings, Inc. (the legacy company) acquired Biomet, Inc. to form a new consolidated company.

Zimmer Biomet (ZBH) Q4 Earnings Meet, Sales Miss Estimates

by Zacks Equity Research

Zimmer Biomet (ZBH) rides high on all segments.

    Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q4 Earnings?

    by Zacks Equity Research

    Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q4.

      Zimmer Biomet Strong on Positive Data From PROGRESS II Study

      by Zacks Equity Research

      Zimmer Biomet (ZBH) consistently endeavors to improve its knee business.

        Zimmer Biomet (ZBH) Surges: Stock Moves 6.1% Higher

        by Zacks Equity Research

        Zimmer Biomet (ZBH) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.

          New Strong Sell Stocks for December 12th

          by Zacks Equity Research

          Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

            Zimmer Biomet Hurt by Supply Delay, Knee Challenges Remain

            by Zacks Equity Research

            Zimmer Biomet (ZBH) struggles with supply delay problem related to some of its products, causing inability to win back lost customers and gain new ones.

              New Strong Sell Stocks for November 20th

              by Zacks Equity Research

              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                Zimmer Biomet (ZBH) Misses Q3 Earnings, Meets Sales Estimate

                by Zacks Equity Research

                Zimmer Biomet (ZBH) posts in line revenues on the back of soft Knees and Hips segments in Q3.

                  Tracey Ryniec headshot

                  5 Earnings All-Stars to Start the Week

                  by Tracey Ryniec

                  With over 1,000 companies reporting, these are some of the best earnings charts to start the week.

                    Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings?

                    by Zacks Equity Research

                    Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q3.

                      Is Zimmer Biomet (ZBH) a Great Stock for Value Investors?

                      by Zacks Equity Research

                      Is Zimmer Biomet (ZBH) a great pick from the value investor's perspective right now? Read on to know more.

                        Zimmer Biomet (ZBH) Launches Persona Partial Knee System

                        by Zacks Equity Research

                        Zimmer Biomet (ZBH) is constantly trying to turn its Knees business around. Keeping in line with the efforts, the company has launched Persona Partial Knee System.

                          New Strong Sell Stocks for September 6th

                          by Zacks Equity Research

                          Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                            Zimmer (ZBH) Plagued by Various Internal and External Issues

                            by Zacks Equity Research

                            Zimmer Biomet (ZBH) continues to suffer a bad patch, entangled with issues including its decade-old CEO's recent exit post a dull earnings season due to poor knee business.

                              New Strong Sell Stocks for August 14th

                              by Zacks Equity Research

                              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                Zimmer (ZBH) Tops Q2 Earnings, Drops View on Dull Sales

                                by Zacks Equity Research

                                Zimmer Biomet's (ZBH) Q2 earnings results disappoint with an unimpressive Knee, Hip and Dental performances.

                                  Zimmer Biomet (ZBH) Misses Q2 Earnings, Meets Sales Estimate

                                  by Zacks Equity Research

                                  Zimmer Biomet's (ZBH) Knees and Hips segment decreases year over year.

                                    Zimmer Biomet's Preliminary Q2 Numbers Solid, CEO Steps Down

                                    by Zacks Equity Research

                                    Indiana-based Zimmer Biomet Holdings, Inc. (ZBH), a leading player in the global musculoskeletal space, recently announced second-quarter 2017 preliminary results.

                                      Zimmer Biomet (ZBH) Launches X-Ray-Based X-PSI Knee System

                                      by Zacks Equity Research

                                      Zimmer Biomet Holdings, Inc. (ZBH) recently launched a X-ray-based Patient Specific Instrument, X-PSI Knee System.

                                        FDA Passes Zimmer Biomet's (ZBH) Zhejiang Facility Issue

                                        by Zacks Equity Research

                                        Zimmer Biomet Holdings, Inc. (ZBH) revealed that the U.S. Food and Drug Administration (FDA) has closed out its 'Warning Letter' related to the company's Zhejiang, China manufacturing facility.

                                          Zimmer Biomet Rides on Spine Business, Knee Challenges Stay

                                          by Zacks Equity Research

                                          On Jun 6, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH).

                                            Zimmer Biomet (ZBH) Beats on Q1 Earnings and Sales Estimates

                                            by Zacks Equity Research

                                            Zimmer Biomet has a Zacks Rank #3 (Hold) but that could change following its first quarter 2017 earnings report which has just released.

                                              Should You Buy Zimmer Biomet (ZBH) Ahead of Earnings?

                                              by Zacks Equity Research

                                              Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

                                                Medical Product Stocks' Earnings on Apr 27: ZBH, RMD & More

                                                by Zacks Equity Research

                                                Let's take a look at the major Medical products stocks slated to release their Jan-Mar 2017 quarter's reports on Apr 27.

                                                  Will Zimmer Biomet (ZBH) Beat Earnings Estimates in Q1?

                                                  by Zacks Equity Research

                                                  Zimmer Biomet Holdings, Inc. (ZBH) is expected to beat earnings when it reports its first-quarter 2017 financial numbers on Apr 27.